William S. Korinek

Chief Executive Officer at Astrocyte Pharmaceuticals, Inc.

Health Technology

Consumer Services

Finance

Profile

William S.
Korinek is the founder and CEO of Astrocyte Pharmaceuticals, Inc. which was founded in 2014.
He is currently a partner at Dreavent, Inc. where he holds the title of Partner.
Dr. Korinek was a Vice President at Pfizer Inc. from 2009 to 2014.
He received his doctorate degree from Harvard University in 2000 and his undergraduate degree from Concordia College (Minnesota) in 1995.

William S. Korinek active positions

Companies	Position	Start
Astrocyte Pharmaceuticals, Inc. Astrocyte Pharmaceuticals, Inc. BiotechnologyHealth Technology Astrocyte Pharmaceuticals, Inc. operates as a drug development company. The firm focuses on neuroprotective strategy to protect and repair neurons that are damaged by selectively stimulating astrocytes. The company was founded by William S. Korinek and James D. Lechleiter in 2014 and is headquartered in Cambridge, MA.	Chief Executive Officer	2014-07-31
Dreavent, Inc. Dreavent, Inc. Investment ManagersFinance Dreavent, Inc (Dreavent) is a venture capital firm founded in 2020 by Gorka Fius and Leo Walter. The firm is headquartered in Cambridge, Massachusetts.	Private Equity Investor	-

All active positions of William S. Korinek

Former positions of William S. Korinek

Companies	Position	End
PFIZER, INC.	Private Equity Investor	2014-06-30

See the detail of William S. Korinek's experience

Training of William S. Korinek

Harvard University	Doctorate Degree
Concordia College (Minnesota)	Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of William S. Korinek's experience

Connections

100 +

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	1
PFIZER, INC.	Health Technology

Private companies	2
Astrocyte Pharmaceuticals, Inc. Astrocyte Pharmaceuticals, Inc. BiotechnologyHealth Technology Astrocyte Pharmaceuticals, Inc. operates as a drug development company. The firm focuses on neuroprotective strategy to protect and repair neurons that are damaged by selectively stimulating astrocytes. The company was founded by William S. Korinek and James D. Lechleiter in 2014 and is headquartered in Cambridge, MA.	Health Technology
Dreavent, Inc. Dreavent, Inc. Investment ManagersFinance Dreavent, Inc (Dreavent) is a venture capital firm founded in 2020 by Gorka Fius and Leo Walter. The firm is headquartered in Cambridge, Massachusetts.	Finance